Q2 FY2026 · ended Jun 30, 2026 · Revenue $26.55M, +64.6% YoY · Filed Aug 13, 2026
Fitlife Brands, Inc. (FTLF) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $26.5 million and net income of $1.9 million. Free cash flow was $3.6 million. As of Jun 30, 2026 it held $1.1 million in cash and investments and $495,000 in total debt.
Revenue
$26.55M
+64.6% vs year-ago quarter
Net income
$1.95M
+11.6% vs year-ago quarter
Operating cash flow
$3.63M
+204.2% vs year-ago quarter
Free cash flow
$3.63M
+205.5% vs year-ago quarter
EPS
$0.20
+11.1% vs year-ago quarter
Dividend per share
None
Shares outstanding
9.39M
+0.0% vs year-ago quarter
Net cash
$594,000
Q2 FY2026
Operating margin
10.9%
TTM
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- FTLF (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Omaha, NE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1374328
- Former names
- BOND LABORATORIES, INC. (until Oct 1, 2013)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $26.5M | $25.3M | -$39.6M | $23.5M | $16.1M |
| Operating income | $3.4M | $3.1M | -$4.8M | $2.3M | $2.5M |
| Net income | $1.9M | $1.7M | -$2.7M | $921,000 | $1.7M |
| Diluted EPS | $0.20 | $0.17 | -$0.27 | $0.09 | $0.18 |
| Operating cash flow | $3.6M | $2.5M | $244,000 | $3.7M | $1.2M |
| Free cash flow | $3.6M | $2.5M | $239,000 | $3.7M | $1.2M |
| Total assets | $102.6M | $104.3M | $106.3M | $110.0M | $62.8M |
| Total liabilities | $55.2M | $58.9M | $62.7M | $68.1M | $21.9M |
| Stockholders' equity | $47.4M | $45.4M | $43.6M | $41.9M | $40.9M |
| Cash and investments | $1.1M | $1.2M | $1.6M | $3.5M | $1.5M |
| Total debt | $495,000 | $599,000 | $705,000 | $47.3M | $6.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Results of operations, Shareholder vote results, Regulation FD disclosure
|
Aug 13, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
May 22, 2026 | May 18, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
All 539 Fitlife Brands, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.